Apex Healthcare Bhd Stock Debt To Equity
| 7090 Stock | 2.49 0.02 0.81% |
Apex Healthcare Bhd fundamentals help investors to digest information that contributes to Apex Healthcare's financial success or failures. It also enables traders to predict the movement of Apex Stock. The fundamental analysis module provides a way to measure Apex Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Apex Healthcare stock.
Apex |
Apex Healthcare Bhd Company Debt To Equity Analysis
Apex Healthcare's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Apex Healthcare Bhd has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Healthcare sector and about the same as Pharmaceuticals (which currently averages 0.0) industry. The debt to equity for all Malaysia stocks is 100.0% higher than that of the company.
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Apex Fundamentals
| Return On Equity | 17.3 | |||
| Current Valuation | 1.52 B | |||
| Price To Book | 3.19 X | |||
| Price To Sales | 1.92 X | |||
| Revenue | 770.76 M | |||
| EBITDA | 92.61 M | |||
| Net Income | 75.41 M | |||
| Total Debt | 14.77 M | |||
| Cash Flow From Operations | 61.82 M | |||
| Market Capitalization | 1.61 B | |||
| Total Asset | 680.14 M | |||
| Z Score | 65.8 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 680.14 M | |||
| Last Dividend Paid | 0.11 |
About Apex Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Apex Healthcare Bhd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Apex Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Apex Healthcare Bhd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Apex Stock
Apex Healthcare financial ratios help investors to determine whether Apex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Apex with respect to the benefits of owning Apex Healthcare security.